Compile Data Set for Download or QSAR
Report error Found 105 Enz. Inhib. hit(s) with Target = 'Adenylate cyclase type 5'
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50010686(dihydrexidine | 10,11-Dihydroxy-5,6,6a,7,8,12b-hex...)
Affinity DataEC50:  51nMAssay Description:Tested for effective dose agonist activity against adenylate cyclase in rat striatal membraneMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50010686(dihydrexidine | 10,11-Dihydroxy-5,6,6a,7,8,12b-hex...)
Affinity DataEC50:  60nMAssay Description:Effective concentration against adenylate cyclaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032523((6aR,12bS)-4-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  151nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032520((6aR,12bS)-3-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  134nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50010686(dihydrexidine | 10,11-Dihydroxy-5,6,6a,7,8,12b-hex...)
Affinity DataEC50:  141nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50010684(N-n-propyldihydrexidine, N-Pr-DHX | CHEMBL299161 |...)
Affinity DataEC50: >10nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032517((6aR,12bS)-2-Ethyl-5,6,6a,7,8,12b-hexahydro-benzo[...)
Affinity DataEC50:  610nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032519((6aR,12bS)-2-Phenyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  10nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032516((6aR,12bS)-4-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Affinity DataEC50:  333nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032521((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Affinity DataEC50:  148nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032522((6aR,12bS)-2-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Affinity DataEC50:  114nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032524((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Affinity DataEC50:  130nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50032518((6aR,12bS)-3-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Affinity DataEC50:  10nMAssay Description:Effective concentration as Adenylate cyclase activity was measured in rat homogenateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50009864(CHEMBL274833 | [2-Methyl-1-(2-morpholin-4-yl-ethyl...)
Affinity DataEC50:  370nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50009854(CHEMBL13078 | [1-(2-Morpholin-4-yl-ethyl)-1H-indol...)
Affinity DataEC50:  275nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50050489([6-Isothiocyanato-1-(2-morpholin-4-yl-ethyl)-1H-in...)
Affinity DataEC50:  1.10E+3nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50050491((4-Isothiocyanato-naphthalen-1-yl)-[2-methyl-1-(2-...)
Affinity DataEC50:  3.00E+3nMAssay Description:Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50010714(CHEMBL68922 | 1-p-Tolyl-2,3,4,5-tetrahydro-1H-benz...)
Affinity DataEC50:  210nMAssay Description:Effective concentration required to stimulate Adenylate cyclaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50004822(CHEMBL24077 | SKF 38393 (+) | SK-383933 | R(+)SKF ...)
Affinity DataEC50:  80nMAssay Description:Effective concentration required to stimulate Adenylate cyclaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50051588(His-Ser-Gln-thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Le...)
Affinity DataEC50:  8nMAssay Description:Ability of the Compound to activate Adenylate cyclase activity was measured by the conversion of [alpha-32P]ATP to 3'5'-cyclic AMPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50090529(2-[1-(Naphthalene-1-sulfonyl)-1H-indol-6-yl]-octah...)
Affinity DataIC50: 7.20nMAssay Description:Antagonistic activity evaluated in adenylyl cyclase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128187((1R,3R)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128192((1S,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128210((1R,3R)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Affinity DataIC50: 600nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128207((1S,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50140057(2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetra...)
Affinity DataIC50: 2.80E+3nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128209((1R,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128203((1R,3S)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50370376(CHEMBL1229920)
Affinity DataIC50: 4.60E+3nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128199((1S,3S)-4-(6-Amino-purin-9-yl)-cyclopent-2-enecarb...)
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128188((1S,3R)-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl]-...)
Affinity DataIC50: 8.20E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128206((1S,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Affinity DataIC50: 9.40E+3nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128191(2-[3-(6-Amino-purin-9-yl)-cyclopentyloxy]-N-hydrox...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibitory concentration against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibitory concentration against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128205(2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyloxy]-N-h...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Rat)
Purdue University

Curated by ChEMBL
LigandPNGBDBM50025883(2'deoxyadenosine | 2'-Deoxyadenosine | 2'-Deox...)
Affinity DataIC50: 1.50E+4nMAssay Description:Compound was evaluated for inhibition of adenylate cyclase from rat brainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2012
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119844(2-{[2-(6-Amino-purin-9-yl)-ethyl]-methyl-amino}-N-...)
Affinity DataIC50: 1.53E+4nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128204((1R,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Affinity DataIC50: 1.63E+4nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128202((1R,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50128195((1R,3R)-[3-(6-Amino-purin-9-yl)-cyclopentyl]-aceti...)
Affinity DataIC50: 2.88E+4nMAssay Description:Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Royal Danish School of Pharmacy

Curated by ChEMBL
LigandPNGBDBM50119842(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Affinity DataIC50: 3.54E+4nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: